3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
31
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urogenital Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Interventions
Surveys and Questionnaires
529
Blood Specimen Collection
406
Surgical Procedures, Operative
152
Radiotherapy
131
Interviews as Topic
131
Drug Therapy
123
Observation
122
Magnetic Resonance Spectroscopy
104
Biopsy
103
Specimen Handling
70
Data Collection
70
Neoadjuvant Therapy
65
Immunohistochemistry
64
Magnetic Resonance Imaging
61
Immune Checkpoint Inhibitors
59
Watchful Waiting
52
Immunotherapy
51
Bevacizumab
50
Positron Emission Tomography Computed Tomography
46
Ultrasonography
44
Hematologic Tests
42
Liquid Biopsy
41
Tomography, X-Ray Computed
40
Therapeutics
40
Radiosurgery
40
Colonoscopy
40
pembrolizumab
37
Hepatectomy
37
Gene Expression Profiling
36
High-Energy Shock Waves
35
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Observational
×
enfortumab vedotin
×
Clear all
NCT06724159
2026-02-17
SOGUG-PRINCIS
Spanish Oncology Genito-Urinary Group
Recruiting
500 enrolled